Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.

The Centers for Disease Control and Prevention recently recommended testing all nursing home residents and patients with COVID-19 symptoms or potential exposure. MA plans must continue not to charge cost sharing (including deductibles, copayments and coinsurance) or apply prior authorization or other utilization management requirements for COVID-19 tests and testing-related services, CMS notes.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has created an Office of Burden Reduction and Health Informatics to build on its Patients over Paperwork…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response June 26 at 1 p.m. ET will host the next webinar in…
Headline
The Food and Drug Administration has partnered with the Critical Path Institute and National Center for Advancing Translational Sciences to launch the CURE…
Headline
The AHA today urged Congress to revise the Improving Medicare Post-Acute Care Transformation Act of 2014 in the next COVID-19 relief package to reflect new…
Headline
The Department of Health and Human Services today said its Office of Minority Health will partner with the Morehouse School of Medicine to deliver education…
Headline
Hospitalization rates for COVID-19 were nearly four times higher for black, and two times higher for Hispanic, Medicare beneficiaries than for white Medicare…